Skip to main content
Solutions
Nexus IB10 point-of-care technology
Microtiter plate assays
Service Measurements
Science
Critical Care Settings
Acute Care Pathways
Sepsis
COVID-19
Acute Care Biomarkers
penKid - kidney function biomarker
bio-ADM - endothelial function biomarker
DPP3 - cardiac depression factor
Collaborations
Network
Clinical Evaluation
Distribution Partners
Biomarker Out-Licensing
Company
About us
Team
Careers
News
Events
Newsletter
Contact us
Resource Center
Downloads
Scientific Publications
Search
(current)
Order
Contact us
Request a Quote
Newsletter
Reset
179 results:
41.
Increased concentrations of bioactive adrenomedullin subsequently to ARNi treatment in chronic systolic heart failure
Arfsten H.
42.
Postoperatively increased bioactive adrenomedullin is related to adverse outcome after complex aortic surgery
Gombert A.
43.
Bioactive adrenomedullin in plasma is associated to biventricular filling pressures in patients with advanced heart failure
Goetze J. P.
44.
Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment
Boorsma E. M.
45.
Added value of serial bio-adrenomedullin measurement in addition to lactate for the prognosis of septic patients admitted to ICU
Blet A.
46.
Alteration of the renin-angiotensin-aldosterone system in shock: Role of the dipeptidyl peptidase 3
Picod A.
47.
An outlook on biomarkers in cardiogenic shock
Iborra-Egea O.
48.
In-hospital mortality and organ failure after open and endovascular thoraco-abdominal aortic surgery can be predicted by increased levels of circulating dipeptidyl peptidase 3
Gombert A.
49.
Angiotensin II treatment in COVID-19 patients: more risk than benefit? A singlecenter experience
Heinicke U.
50.
Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients
Depret F.
Search results 41 until 50 of 179
previous
1
2
3
4
5
6
7
8
9
10
next